Literature DB >> 12459403

Prevalence and characteristics of early-onset type 2 diabetes in Mexico.

Carlos A Aguilar-Salinas1, Rosalba Rojas, Francisco J Gómez-Pérez, Eduardo García, Victoria Valles, Juan Manuel Ríos-Torres, Aurora Franco, Gustavo Olaiz, Jaime Sepúlveda, Juan A Rull.   

Abstract

OBJECTIVE: To investigate the prevalence and characteristics of patients with type 2 diabetes diagnosed before the age of 40 years (early-onset disease) in a nationwide, population-based study.
METHODS: Using a multistage sampling procedure, we enrolled a representative sample of Mexican urban adults aged 20 to 69 years. Weight, height, blood pressure, and plasma levels of glucose, insulin, and other metabolic parameters were measured in all subjects.
RESULTS: We identified 993 subjects with type 2 diabetes, including 143 subjects aged 20 to 39 years (14% of those with diabetes). Subjects with early-onset diabetes had a greater prevalence of obesity and higher plasma insulin and lipid levels than did age-matched controls, and a greater prevalence of high-density lipoprotein cholesterol levels <35 mg/dL and severe hypertriglyceridemia than did older subjects with diabetes. Those (n = 32) with a normal body mass index (20 to 25 kg/m(2)) tended to have insulin deficiency as the main abnormality, whereas the "metabolic syndrome" characterized the remaining 111 subjects with early-onset diabetes.
CONCLUSION: Most patients with early-onset type 2 diabetes in Mexico are obese or overweight, suggesting that obesity treatment and prevention programs may be effective in reducing the prevalence of this disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12459403     DOI: 10.1016/s0002-9343(02)01314-1

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  13 in total

1.  Estimation of covariate effects with current status data and differential mortality.

Authors:  Alberto Palloni; Jason R Thomas
Journal:  Demography       Date:  2013-04

2.  Measuring the impact of diabetes on life expectancy and disability-free life expectancy among older adults in Mexico.

Authors:  Flávia C D Andrade
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2009-12-22       Impact factor: 4.077

3.  Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.

Authors:  Marc DE Hert; Christoph U Correll; Julio Bobes; Marcelo Cetkovich-Bakmas; Dan Cohen; Itsuo Asai; Johan Detraux; Shiv Gautam; Hans-Jurgen Möller; David M Ndetei; John W Newcomer; Richard Uwakwe; Stefan Leucht
Journal:  World Psychiatry       Date:  2011-02       Impact factor: 49.548

4.  WW-domain-containing oxidoreductase is associated with low plasma HDL-C levels.

Authors:  Jenny C Lee; Daphna Weissglas-Volkov; Mira Kyttälä; Zari Dastani; Rita M Cantor; Eric M Sobel; Christopher L Plaisier; James C Engert; Marleen M J van Greevenbroek; John P Kane; Mary J Malloy; Clive R Pullinger; Adriana Huertas-Vazquez; Carlos A Aguilar-Salinas; Teresa Tusie-Luna; Tjerk W A de Bruin; Bradley E Aouizerat; Carla C J van der Kallen; Carlo M Croce; Rami I Aqeilan; Michel Marcil; Jorma S A Viikari; Terho Lehtimäki; Olli T Raitakari; Johanna Kuusisto; Markku Laakso; Marja-Riitta Taskinen; Jacques Genest; Päivi Pajukanta
Journal:  Am J Hum Genet       Date:  2008-08       Impact factor: 11.025

5.  The clinical characteristics of the newly diagnosed early onset (< 40 years old) diabetes in outpatients' clinic.

Authors:  Kyung-Soo Kim; Hyun-Ju Oh; Ji-Woon Kim; Yeo-Kyung Lee; Soo-Kyung Kim; Seok-Won Park; Yoo-Lee Kim; Won-Keun Park; Yong-Wook Cho
Journal:  Korean Diabetes J       Date:  2010-04-30

6.  Estimating diabetes and diabetes-free life expectancy in Mexico and seven major cities in Latin America and the Caribbean.

Authors:  Flavia Andrade
Journal:  Rev Panam Salud Publica       Date:  2009-07

7.  Diabetes is associated with a higher risk of mortality among women in a middle-income country: Results form the Mexican Teacher's cohort study.

Authors:  S Lozano-Esparza; R López-Ridaura; E Ortiz-Panozo; C González-Villalpando; C Aguilar-Salinas; J E Hernández-Ávila; M Hernández-Ávila; M Lajous
Journal:  Diabetes Metab       Date:  2019-09-13       Impact factor: 6.041

8.  Adiponectin trajectories before type 2 diabetes diagnosis: Whitehall II study.

Authors:  Adam G Tabák; Maren Carstensen; Daniel R Witte; Eric J Brunner; Martin J Shipley; Markus Jokela; Michael Roden; Mika Kivimäki; Christian Herder
Journal:  Diabetes Care       Date:  2012-08-28       Impact factor: 19.112

9.  Estimated incidence of cardiovascular complications related to type 2 diabetes in Mexico using the UKPDS outcome model and a population-based survey.

Authors:  Nancy Reynoso-Noverón; Roopa Mehta; Paloma Almeda-Valdes; Rosalba Rojas-Martinez; Salvador Villalpando; Mauricio Hernández-Ávila; Carlos A Aguilar-Salinas
Journal:  Cardiovasc Diabetol       Date:  2011-01-07       Impact factor: 9.951

10.  Contribution of common genetic variation to the risk of type 2 diabetes in the Mexican Mestizo population.

Authors:  Marco Alberto Gamboa-Meléndez; Alicia Huerta-Chagoya; Hortensia Moreno-Macías; Paola Vázquez-Cárdenas; María Luisa Ordóñez-Sánchez; Rosario Rodríguez-Guillén; Laura Riba; Maribel Rodríguez-Torres; María Teresa Guerra-García; Luz Elizabeth Guillén-Pineda; Shweta Choudhry; Laura Del Bosque-Plata; Samuel Canizales-Quinteros; Gustavo Pérez-Ortiz; Fernando Escobedo-Aguirre; Adalberto Parra; Israel Lerman-Garber; Carlos Alberto Aguilar-Salinas; María Teresa Tusié-Luna
Journal:  Diabetes       Date:  2012-08-24       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.